A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins (Q27473027)

6 July 2017

A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins (English)

1 reference

6 July 2017

0 references

0 references

0 references

Yellow fever 17D vaccine

1 reference

1 reference

4

Vincent Deubel

1 reference

6 July 2017

2

Richard Molenkamp

1 reference

6 July 2017

14

Igor S Lukashevich

1 reference

6 July 2017

Peter J Bredenbeek

1

1 reference

6 July 2017

Willy J M Spaan

3

1 reference

6 July 2017

Phillippe Marianneau

5

1 reference

6 July 2017

Maria S Salvato

6

1 reference

6 July 2017

Dmitry Moshkoff

7

1 reference

6 July 2017

Juan Zapata

8

1 reference

6 July 2017

Ilia Tikhonov

9

1 reference

6 July 2017

Jean Patterson

10

1 reference

6 July 2017

Ricardo Carrion

11

1 reference

6 July 2017

Anysha Ticer

12

1 reference

6 July 2017

Kathleen Brasky

13

1 reference

6 July 2017

language of work or name

English

0 references

publication date

18 January 2006

1 reference

6 July 2017

1 reference

6 July 2017

345

1 reference

6 July 2017

299-304

1 reference

6 July 2017

2

1 reference

Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes

6 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388090

Development of a new vaccine for the prevention of Lassa fever

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388090

Attenuation of recombinant yellow fever 17D viruses expressing foreign protein epitopes at the surface

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388090

Yellow fever 17D as a vaccine vector for microbial CTL epitopes

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388090

Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388090

A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388090

Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388090

Identification of Lassa virus glycoprotein signal peptide as a trans-acting maturation factor

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388090

A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388090

Hemorrhagic fever viruses as biological weapons: medical and public health management

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388090

Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388090

Common antiviral cytotoxic t-lymphocyte epitope for diverse arenaviruses

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388090

Identification of a novel consensus sequence at the cleavage site of the Lassa virus glycoprotein

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388090

Imported lassa fever in Germany: molecular characterization of a new lassa virus strain

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388090

Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388090

Experimental studies of arenaviral hemorrhagic fevers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1388090

29 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.001

7 January 2021

1 reference

https://pubmed.ncbi.nlm.nih.gov/16412488

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2005.12.001

1 reference

6 July 2017

1 reference

6 July 2017

1 reference